Arcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of “Buy” from Brokerages
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have been given an average rating of “Buy” by the ten research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation […]
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have been given an average rating of “Buy” by the ten research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation […]
